📌 Key Takeaways
- Topic: What Is Synthetic Amorphous Silica (SAS)? Types, Safety and Regulatory Status
- Keywords: rheology modifier silica
- Published: 2026-11-20 11:04:00
- Field: Silica (SiO₂) raw materials · Inorganic non-metallic materials · Chemicals
Crystalline Silica Dust Hazard: Health Risks and How to Protect Workers
- Silica Powder Malaysia: Suppliers, Grades and Sourcing Options
- Mesoporous silica nanoparticles have poor powder rheology and poor flow properties, due to their low bulk density, small particle size, and high hygroscopicity, which make further processing and formulation, especially with direct compression, difficult [ 104 ]. This issue can be eliminated by granulating the carriers. Flowability and compactibility can also be boosted by granulation [ 86, 104 ]. During granulation, the desired degree of dispersity is attained by agglomeration of the particles, thereby creating a best possible flow characteristic. However, it is true that during granulation, the specific surface area and the pore volume of the carrier may decrease, also decreasing its adsorption capacity, which is a disadvantage from the facet of the API absorption [ 104, 105 ]. However, since this reduction is mostly negligible compared to the total specific surface area, a substantial improvement in its flow properties can considerably improve the overall performance [ 104, 105 ]. The critical parameters for the process are the following: the quantity of granulating liquid, the liquid addition rate, the mixing speed, the process time, and the temperature. Of course, the applied binder also plays an essential part in the process [ 105 ]. These parameters affect the granule size, specific surface area, bulk density, flow properties (Hausner-factor, Carr-index), crushing strength, compressibility, and compactibility [ 105 ].
- Copper Clad Laminate Filler: Silica Types, Dielectric Properties and Selection
- Wet granulation is the most frequently used technique to process MSNs, because of the many possibilities inherent in it [ 106 ]. Conventional wet granulation is well-suited for the granulation of silica nanocarriers, but several things should be considered during implementation. There are two possible sequences: first, the drug loading, followed by the granulation of the loaded carriers [ 104 ], or the opposite way, the granulation of the empty carriers, then loading the drug into the prepared granules. In the first case, during the planning and implementation of the process, special attention must be paid to the critical process parameters to steer clear of premature drug release [ 104 ]. In general, it can be noted that as little moisture as possible should be used during granulation, consequently decreasing the risk of premature drug release. Still, simultaneously, moisture adequate to produce the desired agglomeration must be made sure [ 104 ]. The risk of premature drug release depends to a certain extent on the chemical structure of the API and the carrier. Szewczyk and Prokopowicz developed doxycycline-loaded MSN pellets with prolonged release kinetics [ 40 ]. First, the drug was loaded into the pores, and then pellets were produced from the loaded mesoporous material with other excipients by wet extrusion and spheronization. For comparison, traditional doxycycline pellets were also prepared. This study demonstrated the importance of utilizing mesoporous carriers for the delayed or sustained release of water-soluble drugs. Pelletization was a successful method to reduce the initial burst release of doxycycline; twice the release time was observed compared to traditional pellets [ 40 ]. Szewczyk et al. developed another DDS loaded with an antibiotic compound (cefazolin) for the treatment of osteomyelitis [ 66 ]. The amine-functionalized MSN was successfully loaded with the drug, and because of the powerful interactions between the negatively charged cefazolin and the positively charged surface of the carrier, a prolonged release of 5 days was observed, which made sure a longer antibacterial influence than with classic pellets. This was proven by the microbiological activity assays of the pellets against S. aureus culture [ 66 ]. These results are promising in antibiotic or anticancer therapy, where therapeutic concentration is needed for a longer period [ 40, 66 ]. A comparable outcome was presented in another publication about metformin-containing MSN pellets with prolonged release kinetics [ 85 ]. After drug loading, pellets were formed with the mixture of the preloaded carriers and chitosan solution, and then the pellets were coated with five layers of chitosan. Since the stomach is not considered the best possible absorption surface for metformin, it is advisable to delay the release until conditions in the intestines are ideal for maximum bioavailability. Chitosan plays an important role in this formulation; it slows down and delays the metformin release and offers delayed and prolonged release kinetics, thereby preventing speedy blood level peaks after application [ 85 ]. On the contrary, Wang et al. published a post on MSN pellets filled with poorly water-soluble carbamazepine, and they observed better oral bioavailability compared to commercially available tablets based on in vivo analysis performed on dogs [ 86 ]. In vitro dissolution studies confirmed a raised dissolution rate compared to crystalline carbamazepine due to the amorphous state of the drug within the pores. This immediate-release pellet formulation allows for a reduction in the drug dose, sustaining the same clinical influence [ 86 ].
- What Is an Antiblock Agent for Film? How Silica Prevents Film Blocking
- Silica Supplier in China: How to Find, Verify and Work with Chinese Producers
- 1. Introduction
Silica for Paint: Matting, Anti-Settling and Rheology Functions Explained
What is silica (SiO₂)?
fumed silica market
What is the difference between fumed silica and precipitated silica?
quartz sand supplier Egypt
What drives silica raw material prices?
silica polishing agent 82. Kumarasamy R.V., Natarajan P.M., Umapathy V.R., Roy J.R., Mironescu M., Palanisamy C.P. Clinical applications and therapeutic potentials of advanced nanoparticles: A comprehensive review on completed human clinical trials. Front. Nanotechnol. 2024;6:1479993. doi: 10.3389/fnano.2024.1479993. [ DOI ] [ Google Scholar ]
Cite this article: Silica Raw Materials News. "SiO₂ Explained: Chemical Formula, Structure, Properties and Applications of Silicon Dioxide
." Published 2026-11-20 11:04:00.
Disclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.
/news/article.htmlDisclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.